IBRAIN score

There is 1 paper on IBRAIN score in aging research: 1 observational study in people.

Biomarker

1 paper studies it3 findings

See all 1 papers on IBRAIN score

“The IBRAIN score exhibited a significant ability to reveal the distinct progression of prodromal AD”
A neuroimaging biomarker for Individual Brain-Related Abnormalities In Neurodegeneration (IBRAIN): a cross-sectional studyEClinicalMedicine2023doi:10.1016/j.eclinm.2023.102276
  • Humans1

Upstream

1

Conversion to Alzheimer's disease

downin humans1

1 study
  1. Conversion to Alzheimer's disease is linked with lower IBRAIN score in humans (longitudinal follow-up of individuals converting to AD) (beta = -0.70).

    “the IBRAIN shows comparable sensitivity (beta = -0.70, p < 1 × 10−16) in capturing longitudinal changes in individuals with conversion to AD”

    Humanslongitudinal follow-up of individuals converting to ADbrain

    A neuroimaging biomarker for Individual Brain-Related Abnormalities In Neurodegeneration (IBRAIN): a cross-sectional study

    EClinicalMedicine

More on Conversion to Alzheimer's disease

Associations

2

Alzheimer's disease

upin humans1

1 study
  1. IBRAIN score predicts Alzheimer's disease in humans (Alzheimer's disease versus normal controls) (AUC 0.92).

    “IBRAIN accurately differentiated individuals with AD from NCs (AUC = 0.92)”

    HumansAlzheimer's disease versus normal controlsbrain

    A neuroimaging biomarker for Individual Brain-Related Abnormalities In Neurodegeneration (IBRAIN): a cross-sectional study

    EClinicalMedicine

More on Alzheimer's disease

Progression from mild cognitive impairment to Alzheimer's disease

upin humans1HR 6.52

1 study
  1. IBRAIN score predicts progression from mild cognitive impairment to Alzheimer's disease in individuals with mild cognitive impairment (HR 6.52, 95% CI 4.42–9.62).

    “The IBRAIN score exhibited a significant ability to reveal the distinct progression of prodromal AD”

    Humansin individuals with mild cognitive impairmentbrain

    A neuroimaging biomarker for Individual Brain-Related Abnormalities In Neurodegeneration (IBRAIN): a cross-sectional study

    EClinicalMedicine

More on Progression from mild cognitive impairment to Alzheimer's disease

Latest